Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07311356

Prognosis of Early-onset Anorexia Nervosa

The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Anorexia Nervosa Feeding and Eating Disorders Mental Disorders

Age range

0 year–30 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

This study includes all patients who were hospitalized at Robert Debré Hospital in Paris between 2016 and 2021 for early-onset anorexia nervosa. During follow-up interviews, participants will complete a standardized set of questionnaires assessing their mental and physical health (EDE-Q, PHQ-9, MSI-BPD, GAD-7, and SF-12). The primary outcome is the evaluation of the severity of the eating disorder, measured with the EDE-Q. Secondary outcomes will be derived from the additional questionnaires and will include body mass index (BMI), menstrual status, follow-up data, general well-being, impact of the eating disorder, hospital readmission, suicide attempts, depressive symptoms, borderline personality traits, anxiety, quality of life, educational attainment, occupational status, and treatments received. We hypothesize that approximately 50% of patients will achieve remission three years after hospitalization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • First full hospitalization in the eating disorders unit (EDU) at Robert Debré Hospital and diagnosis of AMP from 2016 to 2021
  • No objection from the minor to the study
  • Proficiency and understanding of the French language
  • Access to digital technology (computer, smartphone, tablet, etc.)

Exclusion criteria

  • Primary diagnosis of ARFID, other unspecified eating disorder

Treatment and study plan

Primary outcomes

  1. Score of Eating Disorder Examination Questionnaire (EDE SQ) scale

    Time frame: 6 months

    the percentage of subjective cure

Secondary outcomes

  1. Identification of predictive factors at admission for the trajectory (remission/relapse)

    Time frame: 6 months

    The number of hospitalizations related to anorexia nerovsa

Study contacts

Contact information is provided by the study sponsor or research team.

Anael AYROLLES, MD

CONTACT

[email protected]

33140032261

Coline STORDEUR, MD

CONTACT

[email protected]

33140032261

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Evalutation of the Prognosis and Quality of Life of Patients Hospitalized for Early-onset Anorexia Nervosa

Acronym: AM2P

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 30, 2025
Registry last updated
Feb 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.